Pharma Mar | PHM - Sales Revenues

Stock Price
96.85
Daily Change
2.20 2.32%
Monthly
12.03%
Yearly
34.89%
Q2 Forecast
92.25

Pharma Mar reported EUR90.2M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Almirall EUR 547.63M 12.83M Dec/2025
Avita Medical AUD 17.61M 805K Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Pharma Mar EUR 90.2M 54.5M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025